Thought Leadership - Spherix Global Insights

Invest in intelligence that delivers

Spherix Thought Leadership

Dermatology

Earlier Diagnosis and Treatment: The Key to Better Outcomes in Hidradenitis Suppurativa

Rheumatology

Chart Audit of Over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations

Rheumatology

Not Yet on Track: Retrospective Chart Analysis Reveals Physician’s Treatment Approaches in SLE Fall Short of New EULAR Guidance

Nephrology

A Complement and B-Cell Modifying Pipeline to Address Unmet Needs in IgA Nephropathy (IgAN)

Nephrology

A Comparative View of Early Career and Established Nephrologist Perspectives

Nephrology

The Untapped Potential of the ADPKD Treatment Landscape

Dermatology

Acceptable Clinical Trial Differences vs Placebo in Plaque Psoriasis

Dermatology

Uptake of Secukinumab in Hidradenitis Suppurativa

Neurology

A KOL Perspective: Exclusive Interview with Dr. Naismith

Rheumatology

Specialists' Comfort with Cutaneous Lupus Erythematosus Reveals Potential Gaps and a Need for Co- Management Strategies

Nephrology

Evolution of Treatment Paradigms in Diabetic Kidney Disease

Neurology

Characterization of Early Adopters of SC FcRn Blockers for gMG

Rheumatology

Amplifying the Lupus Patient Voice: Insights into the Diagnostic Journey and Informational Needs

Nephrology

The Meteoric Rise of SGLT2 Inhibitors in Glomerular Diseases

Nephrology

Genetic Testing in Patients with Focal Segmental Glomerulosclerosis

Nephrology

A Comparative View of IgA Nephropathy Care Across Four Global Regions

Nephrology

Shifts in SGLT2 Inhibitor Initiation in CKD Non-Dialysis Patients

Neurology

Uncovering the Potential of HIF-PH Inhibitors to Treat Renal Anemia

Neurology

The Uptake of Relyvrio™ (sodium phenylbutyrate and taurursodiol) in ALS among General Neurologists Compared to Neuromuscular Specialists and to ALS Center Affiliated Neurologists

Media

AbbVie price target raised to $220 from $212 at Piper Sandler

December 18, 2024

Inflation Reduction Act Likely to Shape Specialty Prescribing Decisions in 2025, According to Spherix Global Insights

December 10, 2024

Patient Chart Audit Reveals Changing Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Dynamics As New Competition Challenges Alexion/Astra Zeneca’s Soliris and Ultomiris

November 21, 2024

Cleanup for the IL-23 class in ulcerative colitis as new drugs ‘rapidly gained significant momentum’: report

November 18, 2024

Talk to an expert

Gianna Melendez
Franchise Head, Dermatology

Jim Hickey
Franchise Head, Gastroenterology

Lynn Price
Franchise Head, Rheumatology

Meghan Weiss
Franchise Head, Nephrology

Bob Shewbrooks
Franchise Head, Neurology

Bob Shewbrooks
Franchise Head, Ophthalmology